United States Biotechnology & Medical Research

First Tracks Biotherapeutics Inc (TRAX)

First Tracks Biotherapeutics witnessed two insider transactions on September 2, 2026, involving Director Joe Anthony Ware. These activities comprised a sale and a proposed divestment totaling approximately 1.76 million dollars each. This selling activity follows a recent earnings report where the firm missed expectations by 28.38 percent, despite a 66.1 percent stock price increase over ninety days.

No insider activity signal

Top insider sells (90, 60d)

Featured in screeners

No insider activity signal

Top insider sells

Ticker: TRAX Exchange: NSM

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Insider activity signals

0 activity signals detected for First Tracks Biotherapeutics Inc

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

2.8

Ware J. Anthony Non-Executive Director

Transaction date 2 Sep 2026

Sale

Price

152.84

Quantity 3,317 -13.6%

Value US$394,023

Comments Filing

2.8

JOE ANTHONY WARE Director Non-Executive Director

Transaction date 2 Sep 2026

Proposed sale

Price

210.05

Quantity 47,575

Value US$512,844

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value	Details
2026-09-04	2026-09-02	S Sale	2.8 Ware J. Anthony Non-Executive Director	3,317 -13.6% 152.84 US$394,023	3,317 -13.6%	152.84	US$394,023
2026-09-02	2026-09-02	PrS Proposed sale	2.8 JOE ANTHONY WARE Director Non-Executive Director	47,575 210.05 US$512,844	47,575	210.05	US$512,844